Prevalence of liver fibrosis and cirrhosis in screening-detected C282Y homozygous subjects

被引：2
|
作者：
Asberg, Arne [1 ]
Hveem, Kristian
Halvorsen, Tore B.
Smethurst, Hanne-Brit G.
机构：
[1] Univ Trondheim Hosp, Dept Clin Chem, NO-7006 Trondheim, Norway
[2] Innherred Hosp, Dept Med, Levanger, Norway
[3] Univ Trondheim Hosp, Dept Pathol, NO-7006 Trondheim, Norway
来源：
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 2007年 / 42卷 / 06期
关键词：
D O I：
10.1080/00365520601076058
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：782 / 783
页数：2
相关论文
共 50 条
  • [21] Longevity and C282Y mutation for haemochromatosis -: Survival of C282Y homozygotes does not preclude screening for HFE mutations -: Reply
    Coppin, H
    Roth, MP
    Blanché, H
    BRITISH MEDICAL JOURNAL, 2003, 327 (7421): : 991 - 991
  • [22] Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels
    Beaton, Melanie
    Adams, Paul C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (06) : 713 - 714
  • [23] Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients
    Fabio, G
    Zarantonello, M
    Mocellin, C
    Bonara, P
    Corengia, C
    Fargion, S
    Fiorelli, G
    JOURNAL OF HEPATOLOGY, 2002, 37 (06) : 753 - 761
  • [24] Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.
    Powell, L
    Dixon, JL
    Ramm, G
    Anderson, G
    Subramaniam, N
    Fletcher, L
    Crawford, D
    Cavanaugh, J
    Bassett, M
    HEPATOLOGY, 2002, 36 (04) : 307A - 307A
  • [25] Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis
    Hickman, PE
    Hourigan, LF
    Powell, LW
    Cordingley, F
    Dimeski, G
    Ormiston, B
    Shaw, J
    Ferguson, W
    Johnson, M
    Ascough, J
    McDonnell, K
    Pink, A
    Crawford, DHG
    GUT, 2000, 46 (03) : 405 - 409
  • [26] Prevalence of C282Y mutation of the hemochromatosis gene in end stage liver disease.
    Alanen, K
    Chakrabarti, S
    Howson, B
    Adams, PC
    HEPATOLOGY, 1998, 28 (04) : 618A - 618A
  • [27] HFE mutations and chronic hepatitis C:: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis
    Erhardt, A
    Maschner-Olberg, A
    Mellenthin, C
    Kappert, G
    Adams, O
    Donner, A
    Willers, R
    Niederau, C
    Häussinger, D
    JOURNAL OF HEPATOLOGY, 2003, 38 (03) : 335 - 342
  • [28] Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance.
    Powell, LW
    Dixon, JL
    Hewett, DG
    Purdie, DM
    Ramm, GA
    Anderson, GJ
    Subramaniam, N
    Fletcher, LM
    Crawford, DH
    Cavanaugh, JA
    Bassett, ML
    HEPATOLOGY, 2003, 38 (04) : 664A - 664A
  • [29] HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis
    Erhardt, A
    Maschner-Olberg, A
    Mellenthin, C
    Kappert, G
    Adams, O
    Donner, A
    Niederau, C
    Haeussinger, D
    JOURNAL OF HEPATOLOGY, 2003, 38 : 139 - 139
  • [30] The effect of heterozygosity for C282Y mutation on fibrosis and liver iron status in chronic hepatitis C.
    Webster, GJM
    Saeb-Parsy, K
    Davies, SE
    Bimpong, A
    Wallace, DF
    Whalley, S
    Marley, R
    Dooley, JS
    Walker, AP
    Dusheiko, GM
    HEPATOLOGY, 1998, 28 (04) : 526A - 526A
12345